🚀 VC round data is live in beta, check it out!
Limes Schlosskliniken Valuation Multiples
Discover revenue and EBITDA valuation multiples for Limes Schlosskliniken and similar public comparables like Concord Medical, Suraksha Diagnostics, Centrum Medyczne ENEL-MED, AirSculpt and more.
Limes Schlosskliniken Overview
About Limes Schlosskliniken
Limes Schlosskliniken AG operates mental and psychosomatic mental health clinic. It specializes in the treatment of stress disorders including depressions, Burnout Syndrome, Posttraumatic stress disorder, Anxiety / obsessive-compulsive disorder, eating disorders, personality disorders, and Somatization disorders such as chronic pain. LIMES Schlosskliniken operates in the market for high-quality private hospitals specializing in psychiatry, psychotherapy, and psychosomatics in Germany and Switzerland.
Founded
N/A
HQ
Employees
200
Website
Sectors
Financials (LTM)
EV
$166M
Limes Schlosskliniken Financials
Limes Schlosskliniken reported last 12-month revenue of $67M and EBITDA of $17M.
In the same LTM period, Limes Schlosskliniken generated $62M in gross profit, $17M in EBITDA, and $10M in net income.
Revenue (LTM)
Limes Schlosskliniken P&L
In the most recent fiscal year, Limes Schlosskliniken reported revenue of $44M and EBITDA of $8M.
Limes Schlosskliniken expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $67M | XXX | $44M | XXX | XXX | XXX |
| Gross Profit | $62M | XXX | $41M | XXX | XXX | XXX |
| Gross Margin | 92% | XXX | 92% | XXX | XXX | XXX |
| EBITDA | $17M | XXX | $8M | XXX | XXX | XXX |
| EBITDA Margin | 26% | XXX | 19% | XXX | XXX | XXX |
| EBIT Margin | 19% | XXX | 11% | XXX | XXX | XXX |
| Net Profit | $10M | XXX | $4M | XXX | XXX | XXX |
| Net Margin | 14% | XXX | 8% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Limes Schlosskliniken Stock Performance
Limes Schlosskliniken has current market cap of $164M, and enterprise value of $166M.
Market Cap Evolution
Limes Schlosskliniken's stock price is $560.86.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $166M | $164M | 1.0% | XXX | XXX | XXX | $12.51 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLimes Schlosskliniken Valuation Multiples
Limes Schlosskliniken trades at 2.5x EV/Revenue multiple, and 9.5x EV/EBITDA.
EV / Revenue (LTM)
Limes Schlosskliniken Financial Valuation Multiples
As of April 19, 2026, Limes Schlosskliniken has market cap of $164M and EV of $166M.
Equity research analysts estimate Limes Schlosskliniken's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Limes Schlosskliniken has a P/E ratio of 16.9x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $164M | XXX | $164M | XXX | XXX | XXX |
| EV (current) | $166M | XXX | $166M | XXX | XXX | XXX |
| EV/Revenue | 2.5x | XXX | 3.8x | XXX | XXX | XXX |
| EV/EBITDA | 9.5x | XXX | 20.0x | XXX | XXX | XXX |
| EV/EBIT | 13.0x | XXX | 32.8x | XXX | XXX | XXX |
| EV/Gross Profit | 2.7x | XXX | 4.1x | XXX | XXX | XXX |
| P/E | 16.9x | XXX | 44.8x | XXX | XXX | XXX |
| EV/FCF | 19.7x | XXX | 56.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Limes Schlosskliniken Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Limes Schlosskliniken Margins & Growth Rates
Limes Schlosskliniken's revenue in the last 12 month grew by 21%.
Limes Schlosskliniken's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.
Limes Schlosskliniken's rule of 40 is 52% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Limes Schlosskliniken's rule of X is 89% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Limes Schlosskliniken Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 21% | XXX | 42% | XXX | XXX | XXX |
| EBITDA Margin | 26% | XXX | 19% | XXX | XXX | XXX |
| EBITDA Growth | 28% | XXX | 91% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 52% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 89% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 8% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 81% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Limes Schlosskliniken Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Limes Schlosskliniken | XXX | XXX | XXX | XXX | XXX | XXX |
| Concord Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Suraksha Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Centrum Medyczne ENEL-MED | XXX | XXX | XXX | XXX | XXX | XXX |
| AirSculpt | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Limes Schlosskliniken M&A Activity
Limes Schlosskliniken acquired XXX companies to date.
Last acquisition by Limes Schlosskliniken was on XXXXXXXX, XXXXX. Limes Schlosskliniken acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Limes Schlosskliniken
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialLimes Schlosskliniken Investment Activity
Limes Schlosskliniken invested in XXX companies to date.
Limes Schlosskliniken made its latest investment on XXXXXXXX, XXXXX. Limes Schlosskliniken invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Limes Schlosskliniken
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Limes Schlosskliniken
| Where is Limes Schlosskliniken headquartered? | Limes Schlosskliniken is headquartered in Germany. |
| How many employees does Limes Schlosskliniken have? | As of today, Limes Schlosskliniken has over 200 employees. |
| Is Limes Schlosskliniken publicly listed? | Yes, Limes Schlosskliniken is a public company listed on Frankfurt Stock Exchange. |
| What is the stock symbol of Limes Schlosskliniken? | Limes Schlosskliniken trades under LIK ticker. |
| When did Limes Schlosskliniken go public? | Limes Schlosskliniken went public in 2019. |
| Who are competitors of Limes Schlosskliniken? | Limes Schlosskliniken main competitors are Concord Medical, Suraksha Diagnostics, Centrum Medyczne ENEL-MED, AirSculpt. |
| What is the current market cap of Limes Schlosskliniken? | Limes Schlosskliniken's current market cap is $164M. |
| What is the current revenue of Limes Schlosskliniken? | Limes Schlosskliniken's last 12 months revenue is $67M. |
| What is the current revenue growth of Limes Schlosskliniken? | Limes Schlosskliniken revenue growth (NTM/LTM) is 21%. |
| What is the current EV/Revenue multiple of Limes Schlosskliniken? | Current revenue multiple of Limes Schlosskliniken is 2.5x. |
| Is Limes Schlosskliniken profitable? | Yes, Limes Schlosskliniken is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Limes Schlosskliniken? | Limes Schlosskliniken's last 12 months EBITDA is $17M. |
| What is Limes Schlosskliniken's EBITDA margin? | Limes Schlosskliniken's last 12 months EBITDA margin is 26%. |
| What is the current EV/EBITDA multiple of Limes Schlosskliniken? | Current EBITDA multiple of Limes Schlosskliniken is 9.5x. |
| What is the current FCF of Limes Schlosskliniken? | Limes Schlosskliniken's last 12 months FCF is $8M. |
| What is Limes Schlosskliniken's FCF margin? | Limes Schlosskliniken's last 12 months FCF margin is 13%. |
| What is the current EV/FCF multiple of Limes Schlosskliniken? | Current FCF multiple of Limes Schlosskliniken is 19.7x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.